Inflazome IP Portfolio Strengthened with Patents Granted ...
https://apnews.com/Business%20Wire/143c03ccd0844e7fae66134d0311f51b
DUBLIN & CAMBRIDGE, United Kingdom & BRISBANE, Australia--(BUSINESS WIRE)--Jan 13, 2020--Inflazome ( inflazome.com), the pioneering inflammasome biotech company developing multiple small molecule drugs that block harmful inflammation, today announces that the United States Patent and Trademark Office (USPTO) and the European Patent Office (EPO) will grant the patent application WO 2016/131098 ...
DA: 59 PA: 75 MOZ Rank: 65